2268 (2268) News
Follow 2268 (2268) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 6 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
WuXi XDC Cayman gets GMP release for Singapore Tuas site
WuXi XDC Cayman Inc. said it received GMP release for its Singapore manufacturing site at Tuas Biomedical Park, including the BCM3 dual-function line and the DP4 facility, enabling global dual-sourcing for bioconjugate m
EQUITY | Sep 21, 2026, 09:51 AM UTC
M
WuXi XDC licenses WuXiTecan-2 ADC payload to Ona Therapeutics
WuXi XDC granted Ona Therapeutics an exclusive global license to its WuXiTecan-2 payload, including an upfront, milestone payments, and tiered royalties, plus CMC development and manufacturing support.
EQUITY | Sep 17, 2026, 08:11 AM UTC
L
WuXi AppTec sells 53,524,000 shares of WuXi XDC via block trade
WuXi AppTec sold 53,524,000 shares in WuXi XDC via a block trade.
EQUITY | Aug 27, 2026, 10:50 PM UTC
M
Wuxi Apptec to dispose 53.5 mln shares in Wuxi XDC
Wuxi Apptec announced it will dispose 53.5 mln shares in Wuxi XDC via a block trade.
EQUITY | Aug 27, 2026, 01:47 PM UTC
L
WuXi XDC Cayman Retains Bull on Strong Growth Visibility — Market Talk
WuXi XDC Cayman Retains Bull on Strong Growth Visibility — Market Talk
EQUITY | Aug 26, 2026, 07:43 AM UTC
L
Target price raised for 2268 by Citi Research
Citi Research raised its target price for 2268 to HK$93.00 from HK$73.00, according to TradingView News.
EQUITY | Aug 26, 2026, 07:36 AM UTC